States and cities continue 'sweetening the deal' with vaccination incentives for young kids
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
With young kids ages 5 to 11 now eligible for Pfizer and BioNTech's COVID-19 vaccine, the shot incentives we've all grown to know and love (and in some cases ignore) will, in some places, continue "sweetening the deal," CNN reports.
In New York City, kids are eligible for $100 or tickets to city attractions (like the Statue of Liberty) if they receive their first dose at a city-operated vaccine site. "We really want kids to take advantage, families take advantage of that," said Mayor Bill de Blasio on Thursday. "We want our kids and our families to be safe."
A similar $100 gift card is available for Chicago children ages 5 to 11 if they get their shot at one of the city's public heath events or clinics, reports CNN. Chicago's large school district is even closing on Nov. 12 for a Vaccination Awareness Day, allowing students an opportunity to get their shots without missing class.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"It is rare that we make a late change to the school calendar, but we see this as an important investment in the future of this school year and the health and wellbeing of our students, staff, and families," Chicago Schools Chief Executive Officer Pedro Martinez told parents, per CNN.
The $100 reward could also soon be available in Louisiana, officials said. And in San Antonio, Texas, any parent or guardian that gets their child vaccinated at a public health clinic is eligible for a $100 grocery store gift card.
As of Thursday, the U.S. had fully vaccinated over 58 percent of its total population, according to CDC data. Read more at CNN.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Political cartoons for February 22Cartoons Sunday’s political cartoons include Black history month, bloodsuckers, and more
-
The mystery of flight MH370The Explainer In 2014, the passenger plane vanished without trace. Twelve years on, a new operation is under way to find the wreckage of the doomed airliner
-
5 royally funny cartoons about the former prince Andrew’s arrestCartoons Artists take on falling from grace, kingly manners, and more
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
